Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol

NCT02669459 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

433

Enrollment

OTHER

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia

Interventions

DRUG: Imiquimod
PROCEDURE: LLETZ

Sponsor

Erasmus Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]